Alexander A Fitzpatrick's most recent trade in ARS Pharmaceuticals Inc was a trade of 102,969 Common Stock done at an average price of $14.1 . Disclosure was reported to the exchange on May 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ARS Pharmaceuticals Inc | Alexander A. Fitzpatrick | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 14.10 per share. | 20 May 2025 | 102,969 | 89,613 | - | 14.1 | 1,451,513 | Common Stock |
| ARS Pharmaceuticals Inc | Alexander A. Fitzpatrick | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2025 | 100,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| ARS Pharmaceuticals Inc | Alexander A. Fitzpatrick | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.58 per share. | 20 May 2025 | 100,000 | 192,582 | - | 5.6 | 558,000 | Common Stock |
| ARS Pharmaceuticals Inc | Alexander A. Fitzpatrick | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 152,300 | 152,300 | - | - | Stock option (right to buy) | |
| ARS Pharmaceuticals Inc | Alexander A. Fitzpatrick | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 300,000 | 300,000 | - | - | Stock option (right to buy) | |
| ARS Pharmaceuticals Inc | Alexander A. Fitzpatrick | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 700,000 | 700,000 | - | - | Stock option (right to buy) |